World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

ADRENAL OLIGOMETASTATIC MALIGNANT PHEOCHROMOCYTOMA

S. Barkiche*, H. Sami, S. Elouarzazi, M. Darfaoui, I. Lalya, A. Elomrani, M. Khouchani

ABSTRACT

Pheochromocytoma is a neuroendocrine tumor derived from the chromaffin cells of the adrenal medulla. Malignancy is defined by the presence of metastases in non-chromaffin tissue or by the appearance of recurrences. About 40% of cases are genetic. It is therefore important to look for symptoms that suggest a genetic predisposition syndrome, particularly the multiple endocrine neoplasia (MEN). The severity of this cancer is due to its rarity, a common cause of delayed diagnosis. Through the observation of our patient followed for malignant pheochromocytoma for 3 years and became oligometastatic, we would like to present the characteristics of this rare disease and to underline the interest of an optimal as well specific management of the tumor, the oligometastases, and associated complications, passing through experienced multidisciplinary teams.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR